Aldeyra Therapeutics Inc (ALDX)
4.81
+0.05
(+1.05%)
USD |
NASDAQ |
Nov 21, 16:00
4.82
+0.01
(+0.21%)
After-Hours: 20:00
Aldeyra Therapeutics Shareholders Equity (Quarterly): 85.10M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 85.10M |
| June 30, 2024 | 98.31M |
| March 31, 2024 | 113.42M |
| December 31, 2023 | 119.80M |
| September 30, 2023 | 123.01M |
| June 30, 2023 | 129.88M |
| March 31, 2023 | 137.24M |
| December 31, 2022 | 151.01M |
| September 30, 2022 | 162.19M |
| June 30, 2022 | 174.03M |
| March 31, 2022 | 190.69M |
| December 31, 2021 | 205.74M |
| September 30, 2021 | 219.67M |
| June 30, 2021 | 233.68M |
| March 31, 2021 | 126.07M |
| December 31, 2020 | 59.51M |
| September 30, 2020 | 69.17M |
| June 30, 2020 | 52.79M |
| March 31, 2020 | 43.47M |
| December 31, 2019 | 48.08M |
| September 30, 2019 | 50.88M |
| June 30, 2019 | 67.33M |
| March 31, 2019 | 78.48M |
| Date | Value |
|---|---|
| December 31, 2018 | 86.62M |
| September 30, 2018 | 28.60M |
| June 30, 2018 | 36.98M |
| March 31, 2018 | 36.00M |
| December 31, 2017 | 39.60M |
| September 30, 2017 | 45.90M |
| June 30, 2017 | 23.34M |
| March 31, 2017 | 28.00M |
| December 31, 2016 | 21.65M |
| September 30, 2016 | 25.67M |
| June 30, 2016 | 29.52M |
| March 31, 2016 | 20.53M |
| December 31, 2015 | 24.88M |
| September 30, 2015 | 28.70M |
| June 30, 2015 | 31.52M |
| March 31, 2015 | 13.83M |
| December 31, 2014 | 6.284M |
| September 30, 2014 | 8.264M |
| June 30, 2014 | 9.815M |
| March 31, 2014 | -1.137M |
| December 31, 2013 | -1.904M |
| September 30, 2013 | -11.76M |
| December 31, 2012 | -25.15M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
43.47M
Minimum
Mar 2020
233.68M
Maximum
Jun 2021
127.14M
Average
124.54M
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie Inc | 6.032B |
| NovaBay Pharmaceuticals Inc | 1.072M |
| Palatin Technologies Inc | -7.686M |
| iBio Inc | 17.75M |
| Theriva Biologics Inc | 24.64M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 117.32M |
| Total Liabilities (Quarterly) | 32.22M |